Detailed price information for Biovaxys Technology Corp (BIOV-CN) from The Globe and Mail including charting and trades.
GSK gets an entry in the list with Exdensur (depemokimab), a twice-yearly injectable IL-5 inhibitor for severe asthma, which ...
How the three-time Olympic medalist became freestyle skiing's biggest star ...
Study Finds on MSN
What If Your Skin Could Warn You About Disease Before Symptoms Appear By Glowing Green?
Green means go…to the doctor In A Nutshell Scientists engineered living skin that glows green when it detects inflammation in ...
Study Finds on MSN
Men Face Double the Odds of Advanced Multiple Myeloma at Diagnosis
In A Nutshell Men have double the odds of presenting with stage III multiple myeloma compared to women, even after accounting ...
AZoLifeSciences on MSN
Engineered human skin acts as a living biosensor for inflammation
Implanted living skin-based biosensors offer a breakthrough in inflammation tracking, providing real-time biomarker ...
Full-year 2025 preliminary1 U.S. net product revenues of $689 millionSYFOVRE® (pegcetacoplan injection) total injection demand grew 17% ...
Registrational myositis trial actively enrolling with planned 17-patient cohort and 2027 rese-cel BLA submission - including an outpatient dosing option using a single weight-based dose IND amendment ...
Phase 2 clinical trial will evaluate the safety, translational biology, and exploratory clinical efficacy of VYD2311 in people with Long COVID or COVID vaccine injuryParticipants to include people ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results